Clinical Trial Update: Efficacy and Safety of GSP 301 Nasal Spray in the Treatment of Seasonal Allergic Rhinitis (SAR) [Phase 3]

View source ↗

Summary

Phase 3 trial results report on the efficacy and safety of GSP 301 nasal spray for seasonal allergic rhinitis. The study results were posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Allergic Rhinitis

Drugs mentioned

• GSP 301 nasal spray

Snippet

Sponsor: Glenmark Specialty S.A. | Conditions: Seasonal Allergic Rhinitis (SAR) | Phase 3 | Status: COMPLETED | Results posted: 2018-04-06